Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

The biggest advantage of the drug going off patent is that the prices will plummet. The patented medicine, sold as Jardiance, ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...